Your browser doesn't support javascript.
loading
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.
Minakata, Daisuke; Fujiwara, Shin-Ichiro; Yokoyama, Daizo; Noguchi, Atsuto; Aoe, Shuka; Oyama, Takashi; Koyama, Shunsuke; Murahashi, Rui; Nakashima, Hirotomo; Hyodo, Kazuki; Ikeda, Takashi; Kawaguchi, Shin-Ichiro; Toda, Yumiko; Ito, Shoko; Nagayama, Takashi; Mashima, Kiyomi; Umino, Kento; Morita, Kaoru; Ashizawa, Masahiro; Yamamoto, Chihiro; Hatano, Kaoru; Sato, Kazuya; Ohmine, Ken; Kanda, Yoshinobu.
Afiliação
  • Minakata D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Fujiwara SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Yokoyama D; Division of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, Japan.
  • Noguchi A; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Aoe S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Oyama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Koyama S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Murahashi R; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Nakashima H; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Hyodo K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ikeda T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Kawaguchi SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Toda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ito S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Nagayama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Mashima K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Umino K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Morita K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ashizawa M; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Yamamoto C; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Sato K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ohmine K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Br J Haematol ; 200(6): 694-703, 2023 03.
Article em En | MEDLINE | ID: mdl-36661264

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão